True Leaf to Present at 7th Annual MicroCap Conference in New York City
04 avr. 2018 07h00 HE
|
True Leaf Medicine International Ltd.
VERNON, British Columbia, April 04, 2018 (GLOBE NEWSWIRE) -- True Leaf Medicine International Ltd. (“True Leaf”) (CSE:MJ) (FSE:TLA) (OTCQB:TRLFF), the quality of life cannabis company for people and...
True Leaf Announces Appointment of Chief Scientific Officer and Medical Advisory Board
27 mars 2018 07h00 HE
|
True Leaf Medicine International Ltd.
VERNON, British Columbia, March 27, 2018 (GLOBE NEWSWIRE) -- True Leaf Medicine International Ltd. (“True Leaf”) (CSE:MJ) (FSE:TLA) (OTCQB:TRLFF), the quality of life cannabis company for people and...
True Leaf Announces Cannabis Cultivation Team
19 mars 2018 07h00 HE
|
True Leaf Medicine International Ltd.
VERNON, British Columbia, March 19, 2018 (GLOBE NEWSWIRE) -- True Leaf Medicine International Ltd. (“True Leaf”) (CSE:MJ) (FSE:TLA) (OTCQB:TRLFF), the quality of life cannabis company for people and...
True Leaf Breaks Ground on North Okanagan Cannabis Production Facility
02 mars 2018 18h07 HE
|
True Leaf Medicine International Ltd.
VERNON, British Columbia, March 02, 2018 (GLOBE NEWSWIRE) -- True Leaf Medicine International Ltd. (“True Leaf”) (CSE:MJ) (FSE:TLA) (OTCQB:TRLFF), the quality of life cannabis company for people and...
BELGRAVIA CAPITAL INTERNATIONAL and Fanlogic Commence Design of Blockchain Loyalty Program for the Global Cannabis Industry
25 janv. 2018 07h00 HE
|
Belgravia Capital International
TORONTO, Jan. 25, 2018 (GLOBE NEWSWIRE) -- BELGRAVIA CAPITAL INTERNATIONAL INC. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia Capital”, “Belgravia”, or the “Company”) is pleased to announce the execution of...
BELGRAVIA CAPITAL INTERNATIONAL receives cash payment, appoints renowned Dermatologist as special advisor to ICP Organics, and provides updates on additional blockchain developments
10 janv. 2018 07h00 HE
|
Belgravia Capital International
TORONTO, Jan. 10, 2018 (GLOBE NEWSWIRE) -- BELGRAVIA CAPITAL INTERNATIONAL INC. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia Capital”, “Belgravia”, or the “Company”) is pleased to announced that the second...
NeutriSci Announces a Major R&D MOU With Scientus Pharma to Develop a Medical Cannabinoid Retail Product
08 janv. 2018 08h30 HE
|
NeutriSci International Inc.
VANCOUVER, British Columbia, Jan. 08, 2018 (GLOBE NEWSWIRE) -- NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX-V:NU) (OTCQB:NRXCF) (FRANKFURT:1N9), the innovator and pioneer behind...
BELGRAVIA CAPITAL INTERNATIONAL announces LOI with R&D Pharma Corp.
04 janv. 2018 07h00 HE
|
Belgravia Capital International
TORONTO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- BELGRAVIA CAPITAL INTERNATIONAL INC. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia Capital”, “Belgravia”, or the “Company”) is pleased to announce the execution of...
Sunniva Inc. Files Preliminary Prospectus
26 sept. 2017 17h18 HE
|
Sunniva Inc.
CALGARY, Alberta, Sept. 26, 2017 (GLOBE NEWSWIRE) -- Sunniva Inc. ("Sunniva" or "the Company"), a North American provider of medical cannabis products and services, has filed its preliminary...
AXIM® Biotech Expands Advisory Board With Oncology Specialist and Medicinal Cannabis Leading Expert – Dr. Donald Abrams
09 mai 2017 09h00 HE
|
AXIM Biotechnologies, Inc
NEW YORK, May 09, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced the addition to its...